CONDENSED STATEMENT OF CASH FLOWS	5 Months Ended
	Sep. 30, 2020 USD ($)
Cash Flows from Operating Activities:
Net loss	$ (156,614)
Adjustments to reconcile net loss to net cash used in operating activities:
Interest earned on marketable securities held in trust account	(210,782)
Unrealized loss on marketable securities	42,999
Deferred tax provision	(9,030)
Changes in operating assets and liabilities:
Prepaid expenses	(1,091,634)
Accrued expenses	33,333
Net cash used in operating activities	(1,391,728)
Cash Flows from Investing Activities:
Investment of cash into Trust Account	(2,070,000,000)
Net cash used in investing activities	(2,070,000,000)
Cash Flows from Financing Activities:
Proceeds from issuance of common stock to Sponsor	25,000
Proceeds from sale of Units, net of underwriting discounts paid	2,033,596,400
Proceeds from sale of Private Placement Warrants	42,850,000
Proceeds from promissory note - related party	550,000
Repayment of promissory note - related party	(550,000)
Payment of offering costs	(861,285)
Net cash provided by financing activities	2,075,610,115
Net Change in Cash	4,218,387
Cash - Ending	4,218,387
Non-Cash investing and financing activities:
Initial classification of common stock subject to possible redemption	1,998,159,110
Change in value of common stock subject to possible redemption	(155,615)
Deferred underwriting fee payable	$ 72,450,000